Rise and shine. Another day is on the way. And here on the Pharmalot corporate campus, where the official mascots are barking and the short people are scurrying off to the school houses, we are preparing for the usual meetings and deadlines. We imagine you are doing the same. So as always, please join us for a needed cup of stimulation and take a moment to peruse the news of the world. We hope your day is productive and please stay in touch...
Vertex Hepatitis C Drug Gets Priority Review (Associated Press)
Merck Confirms Bleeding Risk With New Clotbuster (Reuters)
Perrigo Buys Assets Of Paddock Labs (Bloomberg News)
Forest Labs Says Depression Drug Fails In Study (Associated Press)
UK Plans To Overhaul The NHS (The Guardian)
Parents Upset At FDA Panel Rejection Of Lilly Drug (Xconomy)
Genzyme To Expand Manufacturing In Belgium (Reuters)
Canada Needs Tougher Intellectual Property Rules: Study (Pharma Times)
Boehringer Buys Amgen Site For Biologics Expansion (Outsourcing Pharma)